[{"path":"index.html","id":"about","chapter":"About","heading":"About","text":"","code":""},{"path":"index.html","id":"the-investigators","chapter":"About","heading":"The investigators","text":"Rick Gilmore Professor Psychology Penn State.Andrea Seisler lab manager. also serves Authorizations Support Specialist Databrary. Andrea compiled much information first version protocol document.","code":""},{"path":"hrp-591.html","id":"hrp-591","chapter":"HRP-591","heading":"HRP-591","text":"Protocol Human Subject ResearchProtocol Title:Provide full title study listed item 1 “Basic\nInformation” page CATS IRB (http://irb.psu.edu).Principal Investigator:Name: Rick GilmoreDepartment: PsychologyTelephone: 814-865-3664E-mail Address: rog1@psu.eduVersion Date:Provide version date document. date must updated \ntime document submitted IRB office revisions. \nrevise version date footer document.20220417Clinicaltrials.gov Registration #:Provide registration number study, applicable.\nSee “HRP-103- Investigator Manual”, “ClinicalTrials.gov” information.applicable.Important Instructions Using Protocol\nTemplate:template provided help investigators prepare protocol includes necessary information needed IRB determine whether study meets applicable criteria approval.GENERAL INSTRUCTIONS1:Prior completing protocol, ensure using recent version verifying protocol template version date footer document current version provided CATS IRB Library.Prior completing protocol, ensure using recent version verifying protocol template version date footer document current version provided CATS IRB Library.change protocol template version date located footer document.change protocol template version date located footer document.items may applicable types research. item applicable, please indicate skip question(s) indicated instructional text.items may applicable types research. item applicable, please indicate skip question(s) indicated instructional text.GRAY INSTRUCTIONAL BOXES: Type protocol responses gray instructional boxes guidance language. section item applicable, indicate applicable.GRAY INSTRUCTIONAL BOXES: Type protocol responses gray instructional boxes guidance language. section item applicable, indicate applicable.delete instructional boxes final version protocol.delete instructional boxes final version protocol.protocol written lay language. copy paste grant proposal information protocol.protocol written lay language. copy paste grant proposal information protocol.Add completed protocol template study CATS IRB (http://irb.psu.edu) “Basic Information” page.CATS IRB LIBRARY:Documents referenced protocol template (e.g., SOP’s, Worksheets, Checklists, Templates) can accessed clicking Library link CATS IRB (http://irb.psu.edu).PROTOCOL REVISIONS:making revisions protocol requested IRB, please follow instructions outlined guides available Help Center CATS IRB (http://irb.psu.edu) using track changes.making revisions protocol requested IRB, please follow instructions outlined guides available Help Center CATS IRB (http://irb.psu.edu) using track changes.Update Version Date page 1 time document submitted IRB office revisions.Update Version Date page 1 time document submitted IRB office revisions.need help…locations:Human Research Protection ProgramOffice Research Protections101 Technology Center\nUniversity Park, PA 16802-7014\nPhone: 814-865-1775\nFax: 814-863-8699\nEmail: irb-orp@psu.eduhttps://www.research.psu.edu/irbTable Contents1.0 Objectives2.0 Background3.0 Inclusion Exclusion Criteria4.0 Recruitment Methods5.0 Consent Process Documentation6.0 HIPAA Research Authorization /Waiver Alteration Authorization7.0 Study Design Procedures8.0 Number Subjects Statistical Plan9.0 Data Safety Monitoring Plan10.0 Risks11.0 Potential Benefits Subjects Others12.0 Sharing Results Subjects13.0 Subject Payment /Travel Reimbursements14.0 Economic Burden Subjects15.0 Resources Available16.0 Approvals17.0 Multi-Site Study18.0 Adverse Event Reporting19.0 Study Monitoring, Auditing, Inspecting20.0 Future Undetermined Research: Data Specimen Banking21.0 References22.0 Confidentiality, Privacy Data Management","code":""},{"path":"objectives.html","id":"objectives","chapter":"1 Objectives","heading":"1 Objectives","text":"","code":""},{"path":"objectives.html","id":"study-objectives","chapter":"1 Objectives","heading":"1.1 Study Objectives","text":"Describe purpose, specific aims, objectives.purpose study capture describe state knowledge visual acuity, measured Teller Acuity Card procedure, develops children.\nspecific aims follows:Survey published literature capture main effects database openly shared research community.Query authors published unpublished research using procedure ask contribute individual-level data database. Curate data share research community.Conduct study-level, possible, individual participant-level analyses data determine trajectories development visual acuity, measured particular procedure.","code":""},{"path":"objectives.html","id":"primary-study-endpoints","chapter":"1 Objectives","heading":"1.2 Primary Study Endpoints","text":"State primary endpoints measured study.Research typically primary objective endpoint.\nAdditional objectives endpoints secondary.\nendpoints (outcomes), determined study subject, quantitative measurements required objectives.\nMeasuring selected endpoints goal trial (examples: response rate survival).[Type protocol text indicate applicable]","code":""},{"path":"objectives.html","id":"secondary-study-endpoints","chapter":"1 Objectives","heading":"1.3 Secondary Study Endpoints","text":"State secondary endpoints measured study.[Type protocol text indicate applicable]","code":""},{"path":"background.html","id":"background","chapter":"2 Background","heading":"2 Background","text":"","code":""},{"path":"background.html","id":"scientific-background-and-gaps","chapter":"2 Background","heading":"2.1 Scientific Background and Gaps","text":"Describe scientific background gaps current knowledge.\nclinical research studies conducted Penn State\nHealth/Penn State College Medicine, non-PSH locations\napplicable, describe treatment/procedure considered\nstandard care (.e., indicate patients treated \nnon-investigational setting); applicable, indicate study\nprocedure available patient without taking part study.[Type protocol text ]","code":""},{"path":"background.html","id":"previous-data","chapter":"2 Background","heading":"2.2 Previous Data","text":"Describe relevant preliminary data.[Type protocol text ]","code":""},{"path":"background.html","id":"study-rationale","chapter":"2 Background","heading":"2.3 Study Rationale","text":"Provide scientific rationale research.[Type protocol text ]","code":""},{"path":"inclusion-and-exclusion-criteria.html","id":"inclusion-and-exclusion-criteria","chapter":"3 Inclusion and Exclusion Criteria","heading":"3 Inclusion and Exclusion Criteria","text":"Create numbered list sections 3.1 3.2 criteria subjects must meet eligible study enrollment (e.g., age, gender, diagnosis, etc.).Vulnerable Populations:MAY include members populations subjects \nresearch unless indicate inclusion criteria \nspecific regulations apply studies involve vulnerable\npopulations.checklists referenced outline determinations made IRB reviewing research involving populations. Review checklists help inform responses throughout remainder protocol.Children –Review “HRP-416- Checklist - Children”Pregnant Women – Review “HRP-412- Checklist - Pregnant Women”Cognitively Impaired Adults- Review “HRP-417- Checklist - Cognitively Impaired Adults”Prisoners- Review “HRP-415- Checklist - Prisoners”Neonates uncertain viability non-viable neonates- Review “HRP-413- Checklist - Non-Viable Neonates” “HRP-414- Checklist - Neonates Uncertain Viability”[type ]","code":""},{"path":"inclusion-and-exclusion-criteria.html","id":"inclusion-criteria","chapter":"3 Inclusion and Exclusion Criteria","heading":"3.1 Inclusion Criteria","text":"Create numbered list inclusion criteria define included final study sample (e.g., age, gender, condition, etc.)[Type protocol text ]","code":""},{"path":"inclusion-and-exclusion-criteria.html","id":"does-this-research-involve-collecting-data-from-individuals-residing-outside-of-the-us","chapter":"3 Inclusion and Exclusion Criteria","heading":"3.1.1 Does this research involve collecting data from individuals residing outside of the US?","text":"[ ] \n[ ] Yes – identify countries data collection take place[Type protocol text ]","code":""},{"path":"inclusion-and-exclusion-criteria.html","id":"exclusion-criteria","chapter":"3 Inclusion and Exclusion Criteria","heading":"3.2 Exclusion Criteria","text":"Create numbered list exclusion criteria define excluded study.[Type protocol text ]","code":""},{"path":"inclusion-and-exclusion-criteria.html","id":"early-withdrawal","chapter":"3 Inclusion and Exclusion Criteria","heading":"3.3 Early Withdrawal of Subjects","text":"","code":""},{"path":"inclusion-and-exclusion-criteria.html","id":"criteria-for-removal-from-study","chapter":"3 Inclusion and Exclusion Criteria","heading":"3.3.1 Criteria for removal from study","text":"Insert subject withdrawal criteria (e.g., safety reasons, failure subject adhere protocol requirements, subject consent withdrawal, disease progression, etc.).[Type protocol text indicate applicable]","code":""},{"path":"inclusion-and-exclusion-criteria.html","id":"follow-up-for-withdrawn-subjects","chapter":"3 Inclusion and Exclusion Criteria","heading":"3.3.2 Follow-up for withdrawn subjects","text":"Describe withdraw subjects study; type timing data collected withdrawal subjects; whether subjects replaced; follow-subjects withdrawn investigational treatment.[Type protocol text indicate applicable]","code":""},{"path":"recruitment-methods.html","id":"recruitment-methods","chapter":"4 Recruitment Methods","heading":"4 Recruitment Methods","text":"Upload recruitment materials study CATS IRB (http://irb.psu.edu). include actual recruitment wording protocol.StudyFinder: StudyFinder (http://studyfinder.psu.edu) used recruitment purposes, separate recruitment documents need uploaded CATS IRB. necessary information captured StudyFinder page CATS IRB study.eligibility screening questions (verbal/phone scripts, email, etc.) used contacting potential participants must uploaded study CATS IRB (http://irb.psu.edu).[type ]","code":""},{"path":"recruitment-methods.html","id":"identification-of-subjects","chapter":"4 Recruitment Methods","heading":"4.1 Identification of subjects","text":"Describe source subjects methods used identify potential subjects (e.g., organizational listservs, established recruitment databases, subject pools, medical school records, interactions clinic visit, etc.).\nrecruiting subjects directly (e.g., database query eligible records \nsamples) state queried, .StudyFinder:intend use StudyFinder (http://studyfinder.psu.edu) recruitment purposes, include method section.Information provided protocol, including description study procedures, compensation, recruitment, needs consistent information provided StudyFinder page CATS IRB study.Penn State Health submissions using Enterprise Information Management (EIM) recruitment, non-Hershey locations applicable, attach EIM Design Specification form CATS IRB (http://irb.psu.edu). See “HRP-103- Investigator Manual, Study Recruitment” additional information.include actual recruitment material wording protocol.[Type protocol text ]","code":""},{"path":"recruitment-methods.html","id":"recruitment-process","chapter":"4 Recruitment Methods","heading":"4.2 Recruitment process","text":"Describe potential subjects first learn research opportunity indicate applicable subjects prospectively recruited participant research.\nSubject recruitment can involve various methods (e.g., approaching potential subjects person, contacting potential subjects via email, letters, telephone, ResearchMatch, advertising general public via flyers, websites, StudyFinder, newspaper, television, radio etc.).\ninclude actual recruitment material wording protocol.[type ]","code":""},{"path":"recruitment-methods.html","id":"how-potential-subjects-will-be-recruited","chapter":"4 Recruitment Methods","heading":"4.2.1 How potential subjects will be recruited","text":"[Type protocol text indicate applicable]","code":""},{"path":"recruitment-methods.html","id":"where-potential-subjects-will-be-recruited","chapter":"4 Recruitment Methods","heading":"4.2.2 Where potential subjects will be recruited","text":"[Type protocol text indicate applicable]","code":""},{"path":"recruitment-methods.html","id":"when-potential-subjects-will-be-recruited","chapter":"4 Recruitment Methods","heading":"4.2.3 When potential subjects will be recruited","text":"[Type protocol text indicate applicable]","code":""},{"path":"recruitment-methods.html","id":"describe-the-eligibility-screening-process.-screening-begins-when-the-investigator-obtains-information-about-or-from-a-prospective-participant-in-order-to-determine-their-eligibility.","chapter":"4 Recruitment Methods","heading":"4.2.4 Describe the eligibility screening process. Screening begins when the investigator obtains information about or from a prospective participant in order to determine their eligibility.","text":"[ ] Eligibility screening occurring consent2\n[ ] Eligibility screening occurring consent\n[ ] Consent obtained research\n[ ] applicable - Eligibility screening done research.[Type protocol text ]","code":""},{"path":"consent-process-and-documentation.html","id":"consent-process-and-documentation","chapter":"5 Consent Process and Documentation","heading":"5 Consent Process and Documentation","text":"Refer following materials:\n- “HRP-090- SOP - Informed Consent Process Research” outlines process obtaining informed consent.\n- “HRP-091– SOP - Written Documentation Consent” describes consent process documented.\n- “HRP-314- Worksheet - Criteria Approval” section 7 lists required elements consent.\n- “HRP-312- Worksheet - Exemption Determination” includes information requirements consent process exempt research. addition, CATS IRB Library contains consent guidance templates exempt research.\n- CATS IRB library contains various consent templates expedited full review research designed include required information.\n- Add consent document(s) study CATS IRB (http://irb.psu.edu).\nLinks Penn State’s consent templates available location uploaded. include actual consent wording protocol.[type ]","code":""},{"path":"consent-process-and-documentation.html","id":"consent-process","chapter":"5 Consent Process and Documentation","heading":"5.1 Consent Process","text":"Check applicable boxes :[ ] Informed consent sought documented written consent form [Complete Sections 5.2 5.6; box checked, mark Sections @ref(#waive-doc), 5.4 5.5 ‘applicable’][ ] Implied verbal consent obtained – subjects sign consent form (waiver written documentation consent) [Complete Sections 5.2, 5.3 5.6; box checked, mark Sections 5.4 5.5 ‘applicable’][ ] Informed consent sought elements informed consent omitted altered (e.g., deception). [Complete section 5.2, 5.4 5.6; box checked, mark Section 5.5 ‘applicable’][ ] Informed consent obtained – request completely waive informed consent requirement. [Complete Section 5.5; box checked, mark Sections 5.2, 5.3, 5.4 5.6 ‘applicable’][ ] Exempt Research: believe research activities outlined meet one criteria outlined “HRP-312- Worksheet- Exemption Determination”, check box. checking box, verifying exempt consent process disclose following: Penn State affiliation; name contact information researcher advisor (researcher student); activities involve research; procedures performed; participation voluntary; adequate provisions maintain privacy interests subjects confidentiality data.research includes use student educational records include following language section: parent eligible student provide signed dated written consent discloses: records may disclosed; purpose disclosure; party class parties disclosure may made; parent adult student requests, school provide copy records disclosed; parent student adult requests, school provide student copy records disclosed.Note: box checked, mark Sections 5.3, 5.4, (-consent), 5.6 “applicable.”\ninvestigator’s assessment inaccurate, IRB Analyst request revision protocol ask consent forms recruitment materials submitted.\nExcept exemptions Limited IRB Review required (see “HRP-312- Worksheet- Exemption Determination”) otherwise requested IRB, consent forms recruitment materials generally reviewed approved PSU HRPP research undergoing exempt review.","code":""},{"path":"consent-process-and-documentation.html","id":"obtaining-consent","chapter":"5 Consent Process and Documentation","heading":"5.2 Obtaining Informed Consent","text":"","code":""},{"path":"consent-process-and-documentation.html","id":"consent-process-1","chapter":"5 Consent Process and Documentation","heading":"5.2.1 Consent Process","text":"Describe consent process take place.[Type protocol text ]","code":""},{"path":"consent-process-and-documentation.html","id":"coercion-or-undue-influence-during-consent","chapter":"5 Consent Process and Documentation","heading":"5.2.2 Coercion or Undue Influence during Consent","text":"Describe steps taken minimize possibility coercion undue influence consent process.[Type protocol text ]","code":""},{"path":"consent-process-and-documentation.html","id":"waive-doc","chapter":"5 Consent Process and Documentation","heading":"5.3 Waiver of Written Documentation of Consent","text":"Review “HRP – 411 – Checklist – Waiver Written Documentation Consent.”","code":""},{"path":"consent-process-and-documentation.html","id":"indicate-which-of-the-following-conditions-applies-to-this-research","chapter":"5 Consent Process and Documentation","heading":"5.3.1 Indicate which of the following conditions applies to this research","text":"[ ] research presents minimal risk harm subjects involves procedures written consent normally required outside research context.[ ] record linking subject research consent document principal risk potential harm resulting breach confidentiality. subject asked whether subject wants documentation linking subject research, subject’s wishes govern. (Note: condition applicable FDA-regulated research. category chosen, include copies consent form /parental permission form participants want written documentation linking research.)[ ] subjects legally authorized representatives members distinct cultural group community signing forms norm, research presents minimal risk harm subjects provided appropriate alternative mechanism documenting informed consent obtained. (Note: condition applicable FDA-regulated research.)distinct cultural groups, describe alternative mechanism documenting informed consent obtained.[Type protocol text ]","code":""},{"path":"consent-process-and-documentation.html","id":"indicate-what-materials-if-any-will-be-used-to-inform-potential-subjects-about-the-research-e.g.-a-letter-accompanying-a-questionnaire-verbal-script-or-implied-consent-form.","chapter":"5 Consent Process and Documentation","heading":"5.3.2 Indicate what materials, if any, will be used to inform potential subjects about the research (e.g., a letter accompanying a questionnaire, verbal script, or implied consent form).","text":"[Type protocol text indicate applicable]","code":""},{"path":"consent-process-and-documentation.html","id":"altered-consent","chapter":"5 Consent Process and Documentation","heading":"5.4 Informed consent will be sought but some of the elements of informed consent will be omitted or altered (e.g., deception)","text":"Review “HRP-410-Checklist -Waiver Alteration Consent Process” ensure provided sufficient information.","code":""},{"path":"consent-process-and-documentation.html","id":"indicate-the-elements-of-informed-consent-to-be-omitted-or-altered.","chapter":"5 Consent Process and Documentation","heading":"5.4.1 Indicate the elements of informed consent to be omitted or altered.","text":"[Type protocol text indicate applicable]","code":""},{"path":"consent-process-and-documentation.html","id":"indicate-why-the-research-could-not-practicably-be-carried-out-without-the-omission-or-alteration-of-consent-elements","chapter":"5 Consent Process and Documentation","heading":"5.4.2 Indicate why the research could not practicably be carried out without the omission or alteration of consent elements","text":"[Type protocol text indicate applicable]","code":""},{"path":"consent-process-and-documentation.html","id":"describe-why-the-research-involves-no-more-than-minimal-risk-to-subjects.","chapter":"5 Consent Process and Documentation","heading":"5.4.3 Describe why the research involves no more than minimal risk to subjects.","text":"[Type protocol text indicate applicable]","code":""},{"path":"consent-process-and-documentation.html","id":"describe-why-the-alterationomission-will-not-adversely-affect-the-rights-and-welfare-of-subjects.","chapter":"5 Consent Process and Documentation","heading":"5.4.4 Describe why the alteration/omission will not adversely affect the rights and welfare of subjects.","text":"[Type protocol text indicate applicable]","code":""},{"path":"consent-process-and-documentation.html","id":"if-the-research-involves-using-identifiable-private-information-or-identifiable-biospecimens-describe-why-the-research-could-not-practicably-be-carried-out-without-using-such-information-or-biospecimens-in-an-identifiable-format.","chapter":"5 Consent Process and Documentation","heading":"5.4.5 If the research involves using identifiable private information or identifiable biospecimens, describe why the research could not practicably be carried out without using such information or biospecimens in an identifiable format.","text":"[Type protocol text indicate applicable]","code":""},{"path":"consent-process-and-documentation.html","id":"debriefing","chapter":"5 Consent Process and Documentation","heading":"5.4.6 Debriefing","text":"Explain whether subjects debriefed participation study. subjects debriefed, provide justification . Add debriefing materials study CATS IRB.[Type protocol text indicate applicable]","code":""},{"path":"consent-process-and-documentation.html","id":"no-consent","chapter":"5 Consent Process and Documentation","heading":"5.5 Informed consent will not be obtained – request to completely waive the informed consent requirement","text":"Review “HRP-410-Checklist -Waiver Alteration Consent Process” ensure provided sufficient information.","code":""},{"path":"consent-process-and-documentation.html","id":"indicate-why-the-research-could-not-practicably-be-carried-out-without-the-waiver-of-consent.","chapter":"5 Consent Process and Documentation","heading":"5.5.1 Indicate why the research could not practicably be carried out without the waiver of consent.","text":"[Type protocol text indicate applicable]","code":""},{"path":"consent-process-and-documentation.html","id":"describe-why-the-research-involves-no-more-than-minimal-risk-to-subjects.-1","chapter":"5 Consent Process and Documentation","heading":"5.5.2 Describe why the research involves no more than minimal risk to subjects.","text":"[Type protocol text indicate applicable]","code":""},{"path":"consent-process-and-documentation.html","id":"describe-why-the-alterationomission-will-not-adversely-affect-the-rights-and-welfare-of-subjects.-1","chapter":"5 Consent Process and Documentation","heading":"5.5.3 Describe why the alteration/omission will not adversely affect the rights and welfare of subjects.","text":"[Type protocol text indicate applicable]","code":""},{"path":"consent-process-and-documentation.html","id":"if-the-research-involves-using-identifiable-private-information-or-identifiable-biospecimens-describe-why-the-research-could-not-practicably-be-carried-out-without-using-such-information-or-biospecimens-in-an-identifiable-format.-1","chapter":"5 Consent Process and Documentation","heading":"5.5.4 If the research involves using identifiable private information or identifiable biospecimens, describe why the research could not practicably be carried out without using such information or biospecimens in an identifiable format.","text":"[Type protocol text indicate applicable]","code":""},{"path":"consent-process-and-documentation.html","id":"additional-pertinent-information-after-participation.","chapter":"5 Consent Process and Documentation","heading":"5.5.5 Additional pertinent information after participation.","text":"Explain subjects provided additional pertinent information participation.[Type protocol text indicate applicable]","code":""},{"path":"consent-process-and-documentation.html","id":"consent-other","chapter":"5 Consent Process and Documentation","heading":"5.6 Consent – Other Considerations","text":"","code":""},{"path":"consent-process-and-documentation.html","id":"non-english-speaking-subjects","chapter":"5 Consent Process and Documentation","heading":"5.6.1 Non-English-Speaking Subjects","text":"Indicate language(s) English understood prospective subjects representatives.subjects speak English enrolled, describe process ensure oral written information provided subjects language. Indicate language used obtaining consent.Indicate whether consent process documented writing long form consent documentation short form consent documentation. Review “HRP-091 –SOP- Written Documentation Consent” “HRP-103 -Investigator Manual” ensure provided sufficient information.[Type protocol text indicate applicable]","code":""},{"path":"consent-process-and-documentation.html","id":"cognitively-impaired-adults","chapter":"5 Consent Process and Documentation","heading":"5.6.2 Cognitively Impaired Adults","text":"Refer “HRP-417 -CHECKLIST- Cognitively Impaired Adults” information research involving cognitively impaired adults subjects.","code":""},{"path":"consent-process-and-documentation.html","id":"capability-of-providing-consent","chapter":"5 Consent Process and Documentation","heading":"5.6.2.1 Capability of Providing Consent","text":"Describe process determine whether individual capable consent.[Type protocol text indicate applicable]","code":""},{"path":"consent-process-and-documentation.html","id":"adults-unable-to-consent","chapter":"5 Consent Process and Documentation","heading":"5.6.2.2 Adults Unable to Consent","text":"Describe whether informed consent obtained legally authorized representative. Describe allowed provide informed consent. Describe process used determine individual’s authority consent research.research conducted state Pennsylvania, review “HRP-013 -SOP- Legally Authorized Representatives, Children Guardians” aware individuals state Pennsylvania meet definition “legally authorized representative.”research conducted outside state Pennsylvania, provide information describes individuals authorized applicable law consent behalf prospective subject participation procedure(s) involved research. One method obtaining information legal counsel authority review protocol along definition “children” “HRP-013 -SOP- Legally Authorized Representatives, Children, Guardians.”[Type protocol text indicate applicable]","code":""},{"path":"consent-process-and-documentation.html","id":"assent-of-adults-unable-to-consent","chapter":"5 Consent Process and Documentation","heading":"5.6.2.3 Assent of Adults Unable to Consent","text":"Describe process assent subjects. Indicate whether assent required , , none subjects. , indicate subjects required assent .assent obtained subjects, provide explanation .[Type protocol text indicate applicable]","code":""},{"path":"consent-process-and-documentation.html","id":"subjects-who-are-not-yet-adults-infants-children-teenagers","chapter":"5 Consent Process and Documentation","heading":"5.6.3 Subjects who are not yet adults (infants, children, teenagers)","text":"","code":""},{"path":"consent-process-and-documentation.html","id":"parental-permission","chapter":"5 Consent Process and Documentation","heading":"5.6.3.1 Parental Permission","text":"Describe whether parental permission obtained. permission obtained individuals parents, describe allowed provide permission. Describe process used determine individual’s authority consent child’s general medical care.research conducted state Pennsylvania, review “HRP-013-SOP- Legally Authorized Representatives, Children Guardians” aware individuals state Pennsylvania meet definition “children.”research conducted outside state Pennsylvania, provide information describes persons attained legal age consent treatments procedures involved research, applicable law jurisdiction research conducted. One method obtaining information legal counsel authority review protocol along definition “children” “HRP-013-SOP- Legally Authorized Representatives, Children, Guardians.”[Type protocol text indicate applicable]","code":""},{"path":"consent-process-and-documentation.html","id":"assent-of-subjects-who-are-not-yet-adults","chapter":"5 Consent Process and Documentation","heading":"5.6.3.2 Assent of subjects who are not yet adults","text":"Indicate whether assent obtained , , none children. assent obtained children, indicate children required assent.\nassent children obtained describe whether documented.[Type protocol text indicate applicable]","code":""},{"path":"hipaa-research-authorization-andor-waiver-or-alteration-of-authorization.html","id":"hipaa-research-authorization-andor-waiver-or-alteration-of-authorization","chapter":"6 HIPAA Research Authorization and/or Waiver or Alteration of Authorization","heading":"6 HIPAA Research Authorization and/or Waiver or Alteration of Authorization","text":"section access, use disclosure Protected Health Information (PHI).\nPHI individually identifiable health information (.e., health information containing one 18 identifiers) transmitted maintained form medium Covered Entity Business Associate.\nCovered Entity health plan, health care clearinghouse health care provider transmits health information electronic form.\nSee “HRP-103 -Investigator Manual” list 18 identifiers.requesting waiver/alteration HIPAA authorization, complete sections 6.2 6.3 addition section 6.1. Privacy Rule permits waivers (alterations) authorization research meets certain conditions. Include information accessed waiver/alteration.[type ]","code":""},{"path":"hipaa-research-authorization-andor-waiver-or-alteration-of-authorization.html","id":"authorization-andor-waiver-or-alteration-of-authorization-for-the-uses-and-disclosures-of-phi","chapter":"6 HIPAA Research Authorization and/or Waiver or Alteration of Authorization","heading":"6.1 Authorization and/or Waiver or Alteration of Authorization for the Uses and Disclosures of PHI","text":"Check apply:[ ] applicable, identifiable protected health information (PHI) accessed, used disclosed study. [Mark parts sections 6.2 6.3 applicable][ ] Authorization obtained documented part consent process. [box checked, mark sections 6.2 6.3 applicable][ ] Partial waiver requested recruitment purposes (Check box patients’ medical records accessed determine eligibility consent/authorization obtained). [Complete parts sections 6.2 6.3][ ] Full waiver requested entire research study (e.g., medical record review studies). [Complete parts sections 6.2 6.3][ ] Alteration requested waive requirement written documentation authorization (verbal authorization obtained). [Complete parts sections 6.2 6.3]","code":""},{"path":"hipaa-research-authorization-andor-waiver-or-alteration-of-authorization.html","id":"waiver-or-alteration-of-authorization-for-the-uses-and-disclosures-of-phi","chapter":"6 HIPAA Research Authorization and/or Waiver or Alteration of Authorization","heading":"6.2 Waiver or Alteration of Authorization for the Uses and Disclosures of PHI","text":"","code":""},{"path":"hipaa-research-authorization-andor-waiver-or-alteration-of-authorization.html","id":"access-use-or-disclosure-of-phi-representing-no-more-than-a-minimal-risk-to-the-privacy-of-the-individual","chapter":"6 HIPAA Research Authorization and/or Waiver or Alteration of Authorization","heading":"6.2.1 Access, use or disclosure of PHI representing no more than a minimal risk to the privacy of the individual","text":"","code":""},{"path":"hipaa-research-authorization-andor-waiver-or-alteration-of-authorization.html","id":"plan-to-protect-phi-from-improper-use-or-disclosure","chapter":"6 HIPAA Research Authorization and/or Waiver or Alteration of Authorization","heading":"6.2.1.1 Plan to protect PHI from improper use or disclosure","text":"Include following statement written – ALTER DELETE unless section applicable research involve waiver authorization. section applicable, remove statement indicate applicable.","code":""},{"path":"hipaa-research-authorization-andor-waiver-or-alteration-of-authorization.html","id":"plan-to-destroy-identifiers-or-a-justification-for-retaining-identifiers","chapter":"6 HIPAA Research Authorization and/or Waiver or Alteration of Authorization","heading":"6.2.1.2 Plan to destroy identifiers or a justification for retaining identifiers","text":"Describe plan destroy identifiers earliest opportunity consistent conduct research. Include identifiers destroyed. identifiers retained, provide legal, health research justification retaining identifiers.[Type protocol text indicate applicable]","code":""},{"path":"hipaa-research-authorization-andor-waiver-or-alteration-of-authorization.html","id":"explanation-for-why-the-research-could-not-practicably-be-conducted-without-access-to-and-use-of-phi","chapter":"6 HIPAA Research Authorization and/or Waiver or Alteration of Authorization","heading":"6.2.2 Explanation for why the research could not practicably be conducted without access to and use of PHI","text":"Provide reasons research practicably carried without access use PHI.[Type protocol text indicate applicable]","code":""},{"path":"hipaa-research-authorization-andor-waiver-or-alteration-of-authorization.html","id":"explanation-for-why-the-research-could-not-practicably-be-conducted-without-the-waiver-or-alteration-of-authorization","chapter":"6 HIPAA Research Authorization and/or Waiver or Alteration of Authorization","heading":"6.2.3 Explanation for why the research could not practicably be conducted without the waiver or alteration of authorization","text":"Provide reasons research practicably carried without waiver alternation authorization.[Type protocol text indicate applicable]","code":""},{"path":"hipaa-research-authorization-andor-waiver-or-alteration-of-authorization.html","id":"waiver-or-alteration-of-authorization-statements-of-agreement","chapter":"6 HIPAA Research Authorization and/or Waiver or Alteration of Authorization","heading":"6.3 Waiver or alteration of authorization statements of agreement","text":"submitting study review waiver authorization, agree following statement – ALTER DELETE unless section applicable research involve waiver alteration authorization. section applicable, remove statement indicate applicable.Protected health information obtained part research reused disclosed person entity, except required law, authorized oversight research study, permitted uses disclosures according federal regulations.research team collect information essential study accord ‘Minimum Necessary’ standard (information reasonably necessary accomplish objectives research) per federal regulations.Access information limited, greatest extent possible, within research team. disclosures releases identifiable information granted waiver accounted documented.","code":""},{"path":"study-design-and-procedures.html","id":"study-design-and-procedures","chapter":"7 Study Design and Procedures","heading":"7 Study Design and Procedures","text":"Data collection materials seen used subjects study must uploaded CATS IRB (http://irb.psu.edu). include actual data collection materials protocol (e.g., actual survey interview questions)[type ]","code":""},{"path":"study-design-and-procedures.html","id":"study-design","chapter":"7 Study Design and Procedures","heading":"7.1 Study Design","text":"Describe explain study design.[Type protocol text ]","code":""},{"path":"study-design-and-procedures.html","id":"study-procedures","chapter":"7 Study Design and Procedures","heading":"7.2 Study Procedures","text":"Provide step step description research procedures conducted (broken visit, applicable) including information (applicable); describe following:\n- : (e.g., data collection via interviews, focus groups, forms surveys questionnaires, medical/school records, audio/video/digital recordings, photographs, EKG procedures, MRI, mobile devices electronic tablets/cell phones, observations, collection specimens, experimental drug/device testing, manipulation behavior/use deception, computer games, etc.)\n- : (e.g., classrooms, labs, internet/online, places business, medical settings, public spaces, etc.)[Type protocol text ]","code":""},{"path":"study-design-and-procedures.html","id":"visit-1-or-day-1-or-pre-test-etc.","chapter":"7 Study Design and Procedures","heading":"7.2.1 Visit 1 or Day 1 or Pre-test, etc.","text":"[Type protocol text ]","code":""},{"path":"study-design-and-procedures.html","id":"visit-2-or-day-2-or-post-test-etc.-if-applicable","chapter":"7 Study Design and Procedures","heading":"7.2.2 Visit 2 or Day 2 or Post-test, etc. (If applicable)","text":"[Type protocol text ]","code":""},{"path":"study-design-and-procedures.html","id":"duration-of-participation","chapter":"7 Study Design and Procedures","heading":"7.3 Duration of Participation","text":"[Type protocol text ]","code":""},{"path":"number-of-subjects-and-statistical-plan.html","id":"number-of-subjects-and-statistical-plan","chapter":"8 Number of Subjects and Statistical Plan","heading":"8 Number of Subjects and Statistical Plan","text":"","code":""},{"path":"number-of-subjects-and-statistical-plan.html","id":"number-of-subjects","chapter":"8 Number of Subjects and Statistical Plan","heading":"8.1 Number of Subjects","text":"Indicate maximum number subjects accrued/enrolled. Distinguish number subjects expected enrolled screened, number subjects needed complete research procedures applicable (.e., numbers subjects excluding screen failures.)[Type protocol text ]","code":""},{"path":"number-of-subjects-and-statistical-plan.html","id":"sample-size-determination","chapter":"8 Number of Subjects and Statistical Plan","heading":"8.2 Sample Size Determination","text":"applicable, provide justification sample size outlined section 8.1 include reflections , calculations , power study.[Type protocol text indicate applicable]","code":""},{"path":"number-of-subjects-and-statistical-plan.html","id":"statistical-or-analytic-methods","chapter":"8 Number of Subjects and Statistical Plan","heading":"8.3 Statistical or Analytic Methods","text":"Describe statistical methods (non-statistical methods analysis) employed.[Type protocol text ]","code":""},{"path":"data-and-safety-monitoring-plan.html","id":"data-and-safety-monitoring-plan","chapter":"9 Data and Safety Monitoring Plan","heading":"9 Data and Safety Monitoring Plan","text":"section required research involves Minimal\nRisk subjects defined “HRP-001 SOP- Definitions.”Minimal Risk defined probability magnitude harm discomfort anticipated research greater ordinarily encountered daily life performance routine physical psychological examinations tests.\nresearch involving prisoners, Minimal Risk probability magnitude physical psychological harm normally encountered daily lives, routine medical, dental, psychological examination healthy persons.Please complete section research involves \nminimal risk subjects indicate applicable.[type ]","code":""},{"path":"data-and-safety-monitoring-plan.html","id":"periodic-evaluation-of-data","chapter":"9 Data and Safety Monitoring Plan","heading":"9.1 Periodic evaluation of data","text":"Describe plan periodically evaluate data collected regarding harms benefits determine whether subjects remain safe.[Type protocol text indicate applicable]","code":""},{"path":"data-and-safety-monitoring-plan.html","id":"data-that-are-reviewed","chapter":"9 Data and Safety Monitoring Plan","heading":"9.2 Data that are reviewed","text":"Describe data reviewed, including safety data, untoward events, efficacy data.[Type protocol text indicate applicable]","code":""},{"path":"data-and-safety-monitoring-plan.html","id":"method-of-collection-of-safety-information","chapter":"9 Data and Safety Monitoring Plan","heading":"9.3 Method of collection of safety information","text":"Describe method safety information collected (e.g., case report forms, study visits, telephone calls subjects).[Type protocol text indicate applicable]","code":""},{"path":"data-and-safety-monitoring-plan.html","id":"frequency-of-data-collection","chapter":"9 Data and Safety Monitoring Plan","heading":"9.4 Frequency of data collection","text":"Describe frequency data collection, including safety data collection starts.[Type protocol text indicate applicable]","code":""},{"path":"data-and-safety-monitoring-plan.html","id":"individuals-reviewing-the-data","chapter":"9 Data and Safety Monitoring Plan","heading":"9.5 Individuals reviewing the data","text":"Identify individuals review data. plan might include establishing data safety monitoring committee plan reporting data monitoring committee findings IRB sponsor.[Type protocol text indicate applicable]","code":""},{"path":"data-and-safety-monitoring-plan.html","id":"frequency-of-review-of-cumulative-data","chapter":"9 Data and Safety Monitoring Plan","heading":"9.6 Frequency of review of cumulative data","text":"Describe frequency periodicity review cumulative data.[Type protocol text indicate applicable]","code":""},{"path":"data-and-safety-monitoring-plan.html","id":"statistical-tests","chapter":"9 Data and Safety Monitoring Plan","heading":"9.7 Statistical tests","text":"Describe statistical tests analyzing safety data determine whether harms occurring.[Type protocol text indicate applicable]","code":""},{"path":"data-and-safety-monitoring-plan.html","id":"suspension-of-research","chapter":"9 Data and Safety Monitoring Plan","heading":"9.8 Suspension of research","text":"Describe conditions trigger immediate suspension research.[Type protocol text indicate applicable]","code":""},{"path":"risks.html","id":"risks","chapter":"10 Risks","heading":"10 Risks","text":"List reasonably foreseeable risks, discomforts, hazards, inconveniences subjects related subjects’ participation research. Include may useful IRB’s consideration, description probability, magnitude, duration, reversibility risks.\nConsider types risk including physical, psychological, social, legal, economic risks.\nNote: Loss confidentiality potential risk conducting human subject research must listed .\n- applicable, indicate procedures may risks \nsubjects currently unforeseeable.\n- applicable, indicate procedures may risks embryo\nfetus subject become pregnant.\n- applicable, describe risks others subjects.[Type protocol text ]","code":""},{"path":"potential-benefits-to-subjects-and-others.html","id":"potential-benefits-to-subjects-and-others","chapter":"11 Potential Benefits to Subjects and Others","heading":"11 Potential Benefits to Subjects and Others","text":"","code":""},{"path":"potential-benefits-to-subjects-and-others.html","id":"benefits-subjects","chapter":"11 Potential Benefits to Subjects and Others","heading":"11.1 Potential Benefits to Subjects","text":"Describe potential benefits individual subjects may\nexperience taking part research. direct\nbenefit subjects, indicate . Compensation considered\nbenefit. Compensation addressed section 13.0.[Type protocol text indicate “none” direct\nbenefit subjects]","code":""},{"path":"potential-benefits-to-subjects-and-others.html","id":"benefits-others","chapter":"11 Potential Benefits to Subjects and Others","heading":"11.2 Potential Benefits to Others","text":"Describe potential benefits society others.[Type protocol text ]","code":""},{"path":"sharing-results-with-subjects.html","id":"sharing-results-with-subjects","chapter":"12 Sharing Results with Subjects","heading":"12 Sharing Results with Subjects","text":"Describe whether results (study results individual subject results, results investigational diagnostic tests, genetic tests, incidental findings) shared subjects others (e.g., subject’s primary care physicians) , describe information shared.[Type protocol text indicate applicable]","code":""},{"path":"subject-payment-andor-travel-reimbursements.html","id":"subject-payment-andor-travel-reimbursements","chapter":"13 Subject Payment and/or Travel Reimbursements","heading":"13 Subject Payment and/or Travel Reimbursements","text":"Describe amount, type (cash, check, gift card, ) timing subject payment travel reimbursement.\nsubject payment travel reimbursement, indicate applicable.Extra Course Credit: Describe amount credit available alternatives. Alternatives equal time effort amount course extra credit offered.\nacceptable indicate amount credit determined discretion instructor course.Approved Subject Pool: Indicate approved subject pool used; include response course credit given alternatives offered per approved subject pool procedures.[Type protocol text indicate applicable]","code":""},{"path":"economic-burden-to-subjects.html","id":"economic-burden-to-subjects","chapter":"14 Economic Burden to Subjects","heading":"14 Economic Burden to Subjects","text":"","code":""},{"path":"economic-burden-to-subjects.html","id":"costs","chapter":"14 Economic Burden to Subjects","heading":"14.1 Costs","text":"Describe costs subjects may responsible \nparticipation research.[Type protocol text indicate applicable]","code":""},{"path":"economic-burden-to-subjects.html","id":"compensation-for-research-related-injury","chapter":"14 Economic Burden to Subjects","heading":"14.2 Compensation for research-related injury","text":"research involves Minimal Risk subjects,\ndescribe available compensation event research related\ninjury.sponsor agreement addresses compensation \nmedical care research subjects research-related injury,\ninclude following text written - ALTER DELETE:policy institution provide neither financial\ncompensation free medical treatment research-related injury.\nevent injury resulting research, medical treatment\navailable provided usual charge. Costs \ntreatment research-related injuries charged subjects \ninsurance carriers.sponsored research studies research agreement \nsponsor addresses compensation medical care \nresearch-related injuries, include following text written -\nALTER DELETE:policy institution provide neither financial\ncompensation free medical treatment research-related injury.\nevent injury resulting research, medical treatment\navailable provided usual charge. charges\nmay paid study sponsor outlined research agreement\nexplained consent form.[Enter protocol text outlined instructions indicate applicable]","code":""},{"path":"resources-available.html","id":"resources-available","chapter":"15 Resources Available","heading":"15 Resources Available","text":"","code":""},{"path":"resources-available.html","id":"facilities-and-locations","chapter":"15 Resources Available","heading":"15.1 Facilities and locations","text":"Identify describe facilities, sites, locations \nrecruitment study procedures performed.research conducted outside United States, describe\nsite-specific regulations customs affecting research, \ndescribe process obtaining local ethical review. Also,\ndescribe principal investigator’s experience conducting research\nlocations familiarity local culture.","code":""},{"path":"resources-available.html","id":"feasibility-of-recruiting-the-required-number-of-subjects","chapter":"15 Resources Available","heading":"15.2 Feasibility of recruiting the required number of subjects","text":"Indicate number potential subjects study team \naccess. Indicate percentage potential subjects needed \nrecruitment.[Type protocol text ]","code":""},{"path":"resources-available.html","id":"pi-time-devoted-to-conducting-the-research","chapter":"15 Resources Available","heading":"15.3 PI Time devoted to conducting the research","text":"Describe PI ensure sufficient amount time \ndevoted conducting completing research. Consider outside\nresponsibilities well -going research PI\nresponsible. Please provide response principal\ninvestigator – include information study\nteam members.[Type protocol text ]","code":""},{"path":"resources-available.html","id":"availability-of-medical-or-psychological-resources","chapter":"15 Resources Available","heading":"15.4 Availability of medical or psychological resources","text":"Describe availability medical psychological resources \nsubjects might need result participation study.[Type protocol text indicate applicable]","code":""},{"path":"resources-available.html","id":"process-for-informing-study-team","chapter":"15 Resources Available","heading":"15.5 Process for informing Study Team","text":"Describe training plans ensure members research team informed protocol duties.[Type protocol text indicate applicable principal investigator study team member listed CATS IRB submission][Type protocol text indicate applicable principal investigator study team member listed CATS IRB submission]","code":""},{"path":"other-approvals.html","id":"other-approvals","chapter":"16 Other Approvals","heading":"16 Other Approvals","text":"","code":""},{"path":"other-approvals.html","id":"other-approvals-from-external-entities","chapter":"16 Other Approvals","heading":"16.1 Other Approvals from External Entities","text":"Describe approvals obtained prior commencing \nresearch (e.g., engaged cooperating institutions IRBs \nalso reviewing research required review committees,\ncommunity leaders, schools, research locations research \nconducted Penn State investigator, funding agencies, etc.).[Type protocol text indicate applicable]","code":""},{"path":"other-approvals.html","id":"internal-psu-ancillary-reviews","chapter":"16 Other Approvals","heading":"16.2 Internal PSU Ancillary Reviews","text":"ALTER DELETE:\nAncillary reviews reviewed compliance groups individuals within Penn State inform IRB’s review new study modification existing study.PSU IRB may set applicable ancillary reviews study. Please refer “HRP-309 Worksheet – Ancillary Review Matrix” information (found CATS Library).[type ]","code":""},{"path":"multi-site-study.html","id":"multi-site-study","chapter":"17 Multi-Site Study","heading":"17 Multi-Site Study","text":"multi-site study (.e., study two institutions coordinate, institution completing research activities outlined specific protocol) Penn State PI lead investigator, describe processes ensure communication among sites sections .[type ]","code":""},{"path":"multi-site-study.html","id":"other-sites","chapter":"17 Multi-Site Study","heading":"17.1 Other sites","text":"List name location participating sites. Provide\nname, qualifications contact information principal\ninvestigator site indicate IRB reviewing \nstudy site.[Type protocol text indicate applicable]","code":""},{"path":"multi-site-study.html","id":"communication-plans","chapter":"17 Multi-Site Study","heading":"17.2 Communication Plans","text":"Describe plan regular communication overall study\ndirector sites ensure sites \ncurrent version protocol, consent document, etc. Describe \nprocess ensure modifications communicated sites.\nDescribe process ensure required approvals \nobtained site (including approval site’s IRB \nrecord). Describe process communication problems \nresearch, interim results, closure study.[Type protocol text indicate applicable]","code":""},{"path":"multi-site-study.html","id":"data-submission-and-security-plan","chapter":"17 Multi-Site Study","heading":"17.3 Data Submission and Security Plan","text":"Describe process schedule data submission provide \ndata security plan data collected sites. Describe \nprocess ensure engaged participating sites safeguard data\nrequired local information security policies.[Type protocol text indicate applicable]","code":""},{"path":"multi-site-study.html","id":"subject-enrollment","chapter":"17 Multi-Site Study","heading":"17.4 Subject Enrollment","text":"Describe procedures coordination subject enrollment \nrandomization overall project.[Type protocol text indicate applicable]","code":""},{"path":"multi-site-study.html","id":"reporting-of-adverse-events-and-new-information","chapter":"17 Multi-Site Study","heading":"17.5 Reporting of Adverse Events and New Information","text":"Describe adverse events information reported\nclinical sites overall study director. Provide \ntimeframe reporting.[Type protocol text indicate applicable]","code":""},{"path":"multi-site-study.html","id":"audit-and-monitoring-plans","chapter":"17 Multi-Site Study","heading":"17.6 Audit and Monitoring Plans","text":"Describe process ensure local site investigators conduct\nstudy appropriately. Describe -site auditing monitoring\nplans study.[Type protocol text indicate applicable]","code":""},{"path":"adverse-event-reporting.html","id":"adverse-event-reporting","chapter":"18 Adverse Event Reporting","heading":"18 Adverse Event Reporting","text":"","code":""},{"path":"adverse-event-reporting.html","id":"reporting-adverse-reactions-and-unanticipated-problems-to-the-responsible-irb","chapter":"18 Adverse Event Reporting","heading":"18.1 Reporting Adverse Reactions and Unanticipated Problems to the Responsible IRB","text":"submitting study review, agree following\nstatement – ALTER DELETE:accordance applicable policies Pennsylvania State University Institutional Review Board (IRB), investigator report, IRB, observed reported harm (adverse event) experienced subject individual, opinion investigator determined (1) unexpected; (2) probably related research procedures. Harms (adverse events) submitted IRB accordance IRB policies procedures.","code":""},{"path":"study-monitoring-auditing-and-inspecting.html","id":"study-monitoring-auditing-and-inspecting","chapter":"19 Study Monitoring, Auditing, and Inspecting","heading":"19 Study Monitoring, Auditing, and Inspecting","text":"","code":""},{"path":"study-monitoring-auditing-and-inspecting.html","id":"auditing-and-inspecting","chapter":"19 Study Monitoring, Auditing, and Inspecting","heading":"19.1 Auditing and Inspecting","text":"submitting study review, agree following\nstatement – ALTER DELETE:investigator permit study-related monitoring, audits, inspections Penn State quality assurance program office(s), IRB, sponsor, government regulatory bodies, study related documents (e.g., source documents, regulatory documents, data collection instruments, study data etc.).\ninvestigator ensure capability inspections applicable study-related facilities (e.g., pharmacy, diagnostic laboratory, etc.).","code":""},{"path":"future-undetermined-research-data-and-specimen-banking.html","id":"future-undetermined-research-data-and-specimen-banking","chapter":"20 Future Undetermined Research: Data and Specimen Banking","heading":"20 Future Undetermined Research: Data and Specimen Banking","text":"study collecting identifiable data /specimens\nbanked future undetermined research, please\ndescribe process sections . information \nconflict information provided section 22 \n“HRP-598 – Research Data Plan Review Form” regarding whether \ndata /specimens associated identifiers (directly \nindirectly). plans use identifiable data/specimens\nfuture, undetermined research, section \napplicable.[type ]","code":""},{"path":"future-undetermined-research-data-and-specimen-banking.html","id":"data-andor-specimens-being-stored","chapter":"20 Future Undetermined Research: Data and Specimen Banking","heading":"20.1 Data and/or specimens being stored","text":"Identify data /specimens stored, data associated specimen.[Type protocol text indicate applicable]","code":""},{"path":"future-undetermined-research-data-and-specimen-banking.html","id":"location-of-storage","chapter":"20 Future Undetermined Research: Data and Specimen Banking","heading":"20.2 Location of storage","text":"Identify location data /specimens stored.[Type protocol text indicate applicable]","code":""},{"path":"future-undetermined-research-data-and-specimen-banking.html","id":"duration-of-storage","chapter":"20 Future Undetermined Research: Data and Specimen Banking","heading":"20.3 Duration of storage","text":"Identify long data /specimens stored. data\n/specimens stored indefinitely, indicate .[Type protocol text indicate applicable]","code":""},{"path":"future-undetermined-research-data-and-specimen-banking.html","id":"access-to-data-andor-specimens","chapter":"20 Future Undetermined Research: Data and Specimen Banking","heading":"20.4 Access to data and/or specimens","text":"Identify access data /specimens.","code":""},{"path":"future-undetermined-research-data-and-specimen-banking.html","id":"procedures-to-release-data-or-specimens","chapter":"20 Future Undetermined Research: Data and Specimen Banking","heading":"20.5 Procedures to release data or specimens","text":"Describe procedures release data /specimens,\nincluding: process request release, approvals required \nrelease, can obtain data /specimens, data \nprovided specimens.[Type protocol text indicate applicable]","code":""},{"path":"future-undetermined-research-data-and-specimen-banking.html","id":"process-for-returning-results","chapter":"20 Future Undetermined Research: Data and Specimen Banking","heading":"20.6 Process for returning results","text":"Describe process returning results use data\n/specimens.[Type protocol text indicate applicable]","code":""},{"path":"references.html","id":"references","chapter":"21 References","heading":"21 References","text":"List relevant references literature highlight methods,\ncontroversies, study outcomes.[Type protocol text indicate applicable]","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"confidentiality-privacy-and-data-management","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22 Confidentiality, Privacy and Data Management","text":"IMPORTANT: following section required locations\nEXCEPT Penn State Health College Medicine. Penn State\nHealth College Medicine skip section complete\n“HRP-598 Research Data Plan Review Form.” order avoid\nredundancy, section state “See Research Data Plan Review\nForm” conducting Penn State Health research. Delete \nsub-sections section 22.research conducted Penn State Health Penn State\nHealth researchers : research data security \nintegrity plan submitted using “HRP-598 – Research Data Plan Review\nForm.”order avoid redundancy, section state “See Research\nData Plan Review Form” conducting Penn State Health research.\nDelete sub-sections section 22.[research]: Complete following\nsection. Please refer PSU Policy\nAD95 information regarding\ninformation classification security standards requirements. \nrecommended work local staff planning store,\nprocess, access data electronically ensure plan can \ncarried locally meets applicable requirements. \nquestions Penn State’s Policy AD95 standards need \nconsultation regarding data security, please contact Penn State –\nInformation Security security@psu.edu.","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"which-of-the-following-identifiers-will-be-recorded-for-the-research-project-check-all-that-apply.-if-none-of-the-following-identifiers-will-be-recorded-do-not-check-any-of-the-boxes.","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.1 Which of the following identifiers will be recorded for the research project? Check all that apply. If none of the following identifiers will be recorded, do not check any of the boxes.","text":"","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"if-storing-paper-records-of-research-data-answer-the-following-questions","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.2 If storing paper records of research data, answer the following questions:","text":"","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"where-will-the-paper-records-including-copies-of-signed-consent-forms-associated-with-this-research-study-will-be-stored","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.2.1 Where will the paper records, including copies of signed consent forms, associated with this research study will be stored?","text":"[Type protocol text indicate applicable]","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"how-will-the-paper-records-be-secured","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.2.2 How will the paper records be secured?","text":"[Type protocol text indicate applicable]","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"how-will-access-to-the-paper-records-be-restricted-to-authorized-project-personnel","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.2.3 How will access to the paper records be restricted to authorized project personnel?","text":"[Type protocol text indicate applicable]","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"if-storing-electronic-records-of-research-data-indicate-where-the-electronic-data-associated-with-this-research-study-will-be-stored.-check-all-that-apply.","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.3 If storing electronic records of research data, indicate where the electronic data associated with this research study will be stored. Check all that apply.","text":"[ ] Penn State-provided database application. Check following database applications used (check apply):\n- [ ] Penn State REDCap\n- [ ] – Specify - provided approved database application:[ ] Penn State, College, Department file server[ ] Penn State OneDrive SharePoint[ ] Penn State GoogleDrive[ ] Web-based system provided sponsor cooperative group - Specify URL contact information:[ ] – Specify database application server:Please visit datastoragefinder.psu.edu assistance identifying appropriate data storage options.\nsoftware used appear site, software request form must completed.** list/key links indirect identifiers (code numbers, participant IDs, etc.) direct identifiers, list must comingled (.e., stored location) identifiable data, including copies signed informed consent forms. Additionally, access list/key must restricted authorized project personnel.","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"is-there-a-listkey-that-links-code-numbers-to-identifiers","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.4 Is there a list/key that links code numbers to identifiers?","text":"[ ] Yes - explain list links code identifiers stored separately coded data.identifiers provided voluntarily respondents linked survey responses long identifiers stored researchers.[ ] applicable, list links code numbers identifiers. Skip section 22.6.","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"is-there-a-list-of-people-who-have-access-to-the-listkey","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.5 Is there a list of people who have access to the list/key?","text":"[ ] Yes – explain access list restricted certain persons require access.PI co-investigators IRB protocol access data.[ ] – explain :","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"describe-the-mechanism-in-place-to-ensure-only-approved-research-personnel-have-access-to-the-stored-research-data-electronic-and-paper.","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.6 Describe the mechanism in place to ensure only approved research personnel have access to the stored research data (electronic and paper).","text":"[ ] Password-protected files\n[ ] Role-based securitySpecify mechanisms used ensure permitted users access stored research data:use mobile devices wireless activity trackers collect identifiable research data may approved Penn State - Information Security.","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"will-research-data-be-stored-on-a-mobile-device-such-as-an-electronic-tabletcell-phone-or-will-research-data-be-collected-on-a-wireless-activity-tracker","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.7 Will research data be stored on a mobile device, such as an electronic tablet/cell phone or will research data be collected on a wireless activity tracker?","text":"[ ] – skip 22.8[ ] Yes - answer following questions:","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"specify-the-provider-of-the-tracker-or-mobile-devicess","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.7.1 Specify the provider of the tracker or mobile devices(s)","text":"[ ] Supplied sponsor[ ] Penn State owned device[ ] personal device[ ] – Please specify source: [Type protocol text box checked]","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"specify-the-types-of-tracker-or-mobile-devices-that-will-be-used-to-capture-data-and-all-identifiers-captured-on-the-mobile-devices.-please-list-all-devices-and-if-more-than-one-the-identifiers-to-be-collected-on-each.","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.7.2 Specify the type(s) of tracker or mobile device(s) that will be used to capture data and all identifiers captured on the mobile device(s). Please list all devices, and if more than one, the identifiers to be collected on each.","text":"[Type protocol text ]","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"specify-the-type-of-data-collected-on-the-tracker-or-mobile-devicess.","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.7.3 Specify the type of data collected on the tracker or mobile devices(s).","text":"[Type protocol text ]","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"specify-the-application-or-website-used-to-collect-the-data-from-the-tracker-or-mobile-device-if-applicable.","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.7.4 Specify the application or website used to collect the data from the tracker or mobile device, if applicable.","text":"[Type protocol text ]","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"describe-the-measures-taken-to-protect-the-confidentiality-of-the-data-collected-on-the-tracker-or-mobile-devices.-please-address-physical-security-of-the-devices-electronic-security-and-secure-transfer-of-data-from-devices-to-the-previously-indicated-datafile-storage-location-provided-in-section-22.3.","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.7.5 Describe the measures taken to protect the confidentiality of the data collected on the tracker or mobile device(s). Please address physical security of the device(s), electronic security, and secure transfer of data from device(s) to the previously indicated data/file storage location provided in section 22.3.","text":"use online survey tools email collect send research data containing identifiers represent minimal risk subjects may approved Penn State - Information Security.","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"will-any-research-data-be-directly-enteredsent-by-subjects-over-the-internet-or-via-email-e.g.-data-capture-using-on-line-surveysquestionnaires-surveys-via-email-observation-of-chat-rooms-or-blogs","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.8 Will any research data be directly entered/sent by subjects over the internet or via email (e.g., data capture using on-line surveys/questionnaires, surveys via email, observation of chat rooms or blogs)?","text":"[ ] – skip 22.9[ ] Yes - answer following questions:","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"specify-the-identifiers-collected-over-the-internet-or-via-email-including-ip-addresses-if-ip-addresses-will-be-collected.","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.8.1 Specify the identifiers collected over the internet or via email (Including IP addresses if IP addresses will be collected).","text":"","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"specify-the-type-of-data-collected-over-the-internet-or-via-email.","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.8.2 Specify the type of data collected over the internet or via email.","text":"","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"describe-the-measures-taken-to-protect-the-confidentiality-of-the-data-collected","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.8.3 Describe the measures taken to protect the confidentiality of the data collected?","text":"","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"describe-how-the-research-team-will-access-the-data-once-data-collection-is-complete.","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.8.4 Describe how the research team will access the data once data collection is complete.","text":"","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"if-the-research-involves-online-surveys-list-the-names-of-the-service-providers-that-will-be-used-for-the-surveys-e.g.-redcap-penn-state-licensed-qualtrics-survey-monkey-zoomerang-note-the-irb-strongly-recommends-the-use-of-redcap-for-online-surveys-that-obtain-sensitive-identifiable-human-subjects-data.","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.8.5 If the research involves online surveys, list the name(s) of the service provider(s) that will be used for the survey(s) (e.g., REDCap, Penn State licensed Qualtrics, Survey Monkey, Zoomerang)? (Note: The IRB strongly recommends the use of REDCap for online surveys that obtain sensitive identifiable human subjects data.)","text":"[ ] Penn State REDCap[ ] Penn State Qualtrics[ ] Penn State Microsoft Forms[ ] Penn State Google Forms[ ] - Please specify:\n- Application:\n- URL (applicable):","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"if-the-answer-above-is-other-contact-securitypsu.edu-for-approval-of-an-alternative-data-capture-method","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.8.6 If the answer above is “Other” contact security@psu.edu for approval of an alternative data capture method","text":"Depending nature subject matter involved, certain security requirements must place audio /video recording photographing subjects.\nsubject matter presents minimal risk subjects, , completing section , please contact Penn State - Information Security security@psu.edu confirm whether requirements required.","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"will-any-type-of-recordings-e.g.-audio-or-video-or-photographs-of-the-subjects-be-made-during-this-study","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.9 Will any type of recordings (e.g., audio or video) or photographs of the subjects be made during this study?","text":"[ ] - skip section 22.10[ ] Yes - answer following questions:","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"what-will-be-used-to-capture-the-audiovideoimages-give-a-brief-description-of-content.","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.9.1 What will be used to capture the audio/video/images? Give a brief description of content.","text":"[ ] Audio – Describe intended content audio recording:[Type protocol text ][ ] Video – Describe intended content video recording:[Type protocol text ][ ] Photographs subjects – Describe intended content \nphotographs:[Type protocol text ][ ] 3-D Images – Describe intended content 3-D images:[Type protocol text ][ ] - Specify:[Type protocol text ]","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"how-will-the-recordingsphotographsimages-be-stored-electronically-or-physically","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.9.2 How will the recordings/photographs/images be stored (electronically or physically)?","text":"[Type protocol text ]","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"where-will-the-recordingsphotographsimages-be-stored","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.9.3 Where will the recordings/photographs/images be stored?","text":"[Type protocol text ]","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"who-will-have-access-to-the-recordingsphotographsimages","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.9.4 Who will have access to the recordings/photographs/images?","text":"[Type protocol text ]","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"will-any-of-the-recordings-be-transcribed","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.9.5 Will any of the recordings be transcribed?","text":"[ ] applicable[ ] [ ] Yes – indicate transcribing?[Type protocol text ]","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"will-the-recordingsphotographs-be-used-for-purposes-other-than-this-research-study","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.9.6 Will the recordings/photographs be used for purposes other than this research study?","text":"[ ] [ ] Yes - specify purpose(s) (e.g., publication, presentations, educational training, future undetermined research):[Type protocol text ]","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"certificate-of-confidentiality-coc---is-the-research-biomedical-behavioral-clinical-or-other-research-that-is-funded-by-the-national-institutes-of-health-nih","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.10 Certificate of Confidentiality (COC) - Is the research biomedical, behavioral, clinical or other research that is funded by the National Institutes of Health (NIH)?","text":"[ ] Yes - check one following:\n- [ ] research involves human subjects defined DHHS regulations (See Worksheet HRP-310).\n- [ ] research involves collecting using biospecimens identifiable individual.\n- [ ] collecting using biospecimens part research, small risk combination biospecimen, request biospecimen, available data sources used deduce identity individual.\n- [ ] research involves generation individual level, human\ngenomic data.Note: [] 4 items checked, COC automatically issued NIH applies research. Information COC must included consent form.[ ] - answer following question.\n- [ ] research funded NIH, investigator apply COC research study?\n- [ ] Yes\n- [x] NoNote: research funded NIH, IRB may require COC \nresearch collecting personally identifiable information \ninformation sensitive /research collecting information\ndisclosed significantly harm damage subject.","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"what-steps-will-be-taken-to-protect-subjects-privacy-interests-check-all-that-apply.","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.11 What steps will be taken to protect subjects’ privacy interests? (Check all that apply.)","text":"[ ] Identification recruitment potential subjects follows\nprocedures consistent privacy standards[ ] Consent discussion research interventions take place \nprivate setting[ ] Limiting information collected minimum amount \ndata necessary accomplish research purposes[ ] Limiting people access identifiable research data \nminimum necessary specified application consent\nprocess[ ] – Specify:[Type protocol text ]","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"what-is-the-process-for-ensuring-correctness-of-data-entry","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.12 What is the process for ensuring correctness of data entry?","text":"[ ] Double data entry reduce risk errors[ ] Electronic edit checks ensure data entered obviously\nincorrect[ ] Random internal quality assurance checking research data[ ] Direct entry subjects[ ] - Specify:[Type protocol text ]","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"does-this-research-involve-the-generation-of-large-scale-human-genomic-data-as-defined-in-nih-genomic-data-sharing-policy-httpgds.nih.gov","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.13 Does this research involve the generation of large-scale human genomic data as defined in NIH Genomic Data Sharing Policy (http://gds.nih.gov)?","text":"[ ] [ ] Yes – describe plan de-identifying dataset sharing\nNIH-designated data repositories.[Type protocol text ]Note: Data sharing NIH-designated data repository may require execution institutional certificate.\nPlease review ‘Institutional Certification NIH Genomic Data Sharing’ section Investigator’s Manual information seeking institutional certification.","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"does-this-research-involve-transfer-or-disclosure-of-data-andor-specimens-to-andor-from-penn-state","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.14 Does this research involve transfer or disclosure of data and/or specimens to and/or from Penn State?","text":"[ ] - skip remainder section 22.14[ ] Yes - answer following questions:Check apply:","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"data-are-being-transferred-or-disclosed-to-penn-state","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.14.1 Data are being transferred or disclosed to Penn State","text":"name third party(ies) (institution, sponsor,\netc.) sending providing data?[Type protocol text ]third party requiring us sign contract regarding data?","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"yes---this-contract-must-go-through-the-office-of-sponsored-programs-httpswww.research.psu.eduospoverview-pagesdata-use-agreements","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.14.1.1 [ ] Yes - this contract must go through the Office of Sponsored Programs https://www.research.psu.edu/osp/overview-pages/data-use-agreements","text":"","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"no","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.14.1.2 [ ] No","text":"","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"data-are-being-transferred-or-disclosed-from-penn-state","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.14.2 Data are being transferred or disclosed from Penn State","text":"name(s) third party(ies) (institution, sponsor, etc.) receiving accessing data?[Type protocol text ]Note: Data transfers disclosures may require Data Use Agreement\n(DUA).","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"specimens-are-being-transferred-to-penn-state","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.14.3 Specimens are being transferred to Penn State","text":"name(s) third party(ies) (institution, sponsor,\netc.) sending specimens?[Type protocol text ]","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"specimens-are-being-transferred-from-penn-state","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.14.4 Specimens are being transferred from Penn State","text":"name(s) third party(ies) (institution, sponsor,\netc.) receiving specimens?[Type protocol text ]Note: material transfers, either sending receiving, require \nMaterial Transfer Agreement (MTA). Please contact Office \nTechnology Management information.","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"describe-how-the-dataspecimens-will-be-securely-transferred-or-disclosed-tofrom-the-third-partyies.","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.14.5 Describe how the data/specimens will be securely transferred or disclosed to/from the third party(ies).","text":"[Type protocol text ]","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"how-are-the-research-dataspecimens-being-transferred-from-andor-sent-to-the-third-partyies-complete-the-appropriate-sections-and-check-all-that-apply-within-each-completed-section.","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.14.6 22.14.6 How are the research data/specimens being transferred from and/or sent to the third party(ies)? Complete the appropriate section(s) and check all that apply within each completed section.","text":"","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"data-being-transferred-or-disclosed-to-penn-state","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.14.6.1 22.14.6.1 Data being transferred or disclosed to Penn State:","text":"[ ] Data received aggregate/metrics (just counts, \nindividual data)[ ] De-identified individual data received \nlinking list either institution (identifiers, links \nidentifiers, code numbers)[ ] Coded research data without identifiers \nreceived linking list remains entity sending \ndata; recipient data access \nlinking list[ ] Coded research data identifiers (dates\n/identifiers listed section 22.14.7 aside \nStudy Code) received linking list remains \nentity sending data; recipient data \naccess linking list[ ] Data identifiers (dates /\nidentifiers listed section 22.14.7) received \nlinking list remains entity sending data; recipient\ndata access linking list[ ] Data identifiers along linking list \nreceived[ ] – Specify:[Type protocol text box checked]","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"data-being-transferred-or-disclosed-from-penn-state","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.14.6.2 22.14.6.2 Data being transferred or disclosed from Penn State:","text":"[ ] Data sent aggregate/metrics (just counts, individual\ndata)[ ] De-identified individual data sent linking\nlist either institution (identifiers, links identifiers,\ncode numbers)[ ] Coded research data without identifiers \nsent linking list remains entity sending data;\nrecipient data access \nlinking list[ ] Coded research data identifiers (dates\n/identifiers listed section 22.14.7 aside \nStudy Code) sent linking list remains \nentity sending data; recipient data \naccess linking list[ ] Data identifiers (dates /\nidentifiers listed section 22.14.7) sent linking\nlist remains entity sending data; recipient \ndata access linking list[ ] Data identifiers along linking list \nsent[ ] – Specify:[Type protocol text box checked]","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"specimens-being-transferred-or-disclosed-to-penn-state","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.14.6.3 22.14.6.3 Specimens being transferred or disclosed to Penn State:","text":"[ ] De-identified specimens received linking\nlist either institution (identifiers, links identifiers,\ncode numbers)[ ] Coded specimens without identifiers \nreceived linking list remains entity sending \nspecimens; recipient specimens \naccess linking list[ ] Coded specimens identifiers (dates /\nidentifiers listed section 22.14.7 aside Study\nCode) received linking list remains entity\nsending specimens; recipient specimens \naccess linking list[ ] Coded specimens identifiers (dates /\nidentifiers listed section 22.14.7) received\nlinking list remains entity sending specimens;\nrecipient specimens access \nlinking list[ ] Coded specimens identifiers along linking\nlist receivedOther – Specify:[Type protocol text box checked]","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"specimens-being-transferred-or-disclosed-from-penn-state","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.14.6.4 22.14.6.4 Specimens being transferred or disclosed from Penn State:","text":"[ ] De-identified specimens sent linking list \neither institution (identifiers, links identifiers, \ncode numbers)[ ] Coded specimens without identifiers sent\nlinking list remains entity sending specimens;\nrecipient specimens access \nlinking list[ ] Coded specimens identifiers (dates /\nidentifiers listed section 22.14.7 aside Study\nCode) sent linking list remains entity\nsending specimens; recipient specimens \naccess linking list[ ] Coded specimens identifiers (dates /\nidentifiers listed section 22.14.7) sent \nlinking list remains entity sending specimens; \nrecipient specimens access \nlinking list[ ] Coded specimens identifiers along linking\nlist sent[ ] – Specify:[Type protocol text box checked]","code":""},{"path":"confidentiality-privacy-and-data-management.html","id":"if-transferring-dataspecimens-with-identifiers-to-or-from-penn-state-which-of-the-following-identifiers-will-be-included-with-the-dataspecimens-check-all-that-apply","chapter":"22 Confidentiality, Privacy and Data Management","heading":"22.14.7 22.14.7 If transferring data/specimens with identifiers to or from Penn State, which of the following identifiers will be included with the data/specimens? Check all that apply:","text":"","code":""},{"path":"individual-participant-data.html","id":"individual-participant-data","chapter":"23 Individual participant data","heading":"23 Individual participant data","text":"","code":""},{"path":"individual-participant-data.html","id":"overview","chapter":"23 Individual participant data","heading":"23.1 Overview","text":"","code":""},{"path":"individual-participant-data.html","id":"literature-search","chapter":"23 Individual participant data","heading":"23.2 Literature search","text":"","code":""},{"path":"individual-participant-data.html","id":"data-entry","chapter":"23 Individual participant data","heading":"23.3 Data entry","text":"","code":""},{"path":"meta-analysis.html","id":"meta-analysis","chapter":"24 Meta-analysis","heading":"24 Meta-analysis","text":"","code":""},{"path":"meta-analysis.html","id":"overview-1","chapter":"24 Meta-analysis","heading":"24.1 Overview","text":"","code":""},{"path":"meta-analysis.html","id":"literature-search-1","chapter":"24 Meta-analysis","heading":"24.2 Literature search","text":"","code":""},{"path":"meta-analysis.html","id":"data-entry-1","chapter":"24 Meta-analysis","heading":"24.3 Data entry","text":"","code":""},{"path":"data-mgmt-plan.html","id":"data-mgmt-plan","chapter":"Data Management and Sharing Plan","heading":"Data Management and Sharing Plan","text":"following updated 2023-03-01. based document OMB . 0925-0001 0925-0002 (Rev. 07/2022 Approved TBD).Note following contains URLs provided user. prohibited document submitted NIH. Since document part NIH study, provide transparency.proposed research application involves generation scientific data, application subject NIH Policy Data Management Sharing requires submission Data Management Sharing Plan. proposed research application generate large-scale genomic data, Genomic Data Sharing Policy also applies addressed Plan. Refer detailed instructions application guide developing plan well additional guidance https://sharing.nih.gov. Plan recommended exceed two pages. Text italics deleted. “form page” Data Management Sharing Plan. DMS Plan may provided format shown .Public reporting burden collection information estimated average 2 hours per response, including time reviewing instructions, searching existing data sources, gathering, maintaining data needed, completing reviewing collection information. agency may conduct sponsor, person required respond , collection information unless displays currently valid OMB control number. Send comments regarding burden estimate aspect collection information, including suggestions reducing burden, : NIH, Project Clearance Branch, 6705 Rockledge Drive, MSC 7974, Bethesda, MD 20892-7974, ATTN: PRA (0925-0001 0925-0002). return completed form address.","code":""},{"path":"data-mgmt-plan.html","id":"element-1-data-type","chapter":"Data Management and Sharing Plan","heading":"Element 1: Data Type","text":"","code":""},{"path":"data-mgmt-plan.html","id":"a.-types-and-amount-of-scientific-data-expected-to-be-generated-in-the-project","chapter":"Data Management and Sharing Plan","heading":"A. Types and amount of scientific data expected to be generated in the project:","text":"Summarize types estimated amount scientific data expected generated project.","code":""},{"path":"data-mgmt-plan.html","id":"b.-scientific-data-that-will-be-preserved-and-shared-and-the-rationale-for-doing-so","chapter":"Data Management and Sharing Plan","heading":"B. Scientific data that will be preserved and shared, and the rationale for doing so:","text":"Describe scientific data project preserved shared provide rationale decision.","code":""},{"path":"data-mgmt-plan.html","id":"c.-metadata-other-relevant-data-and-associated-documentation","chapter":"Data Management and Sharing Plan","heading":"C. Metadata, other relevant data, and associated documentation:","text":"Briefly list metadata, relevant data, associated documentation (e.g., study protocols data collection instruments) made accessible facilitate interpretation scientific data.full protocol, including survey questions shared publicly via website code/documentation sharing website, GitHub.","code":""},{"path":"data-mgmt-plan.html","id":"element-2-related-tools-software-andor-code","chapter":"Data Management and Sharing Plan","heading":"Element 2: Related Tools, Software and/or Code:","text":"State whether specialized tools, software, /code needed access manipulate shared scientific data, , provide name(s) needed tool(s) software specify can accessed.","code":""},{"path":"data-mgmt-plan.html","id":"element-3-standards","chapter":"Data Management and Sharing Plan","heading":"Element 3: Standards","text":"State common data standards applied scientific data associated metadata enable interoperability datasets resources, provide name(s) data standards applied describe data standards applied scientific data generated research proposed project. applicable, indicate consensus standards exist.consensus standards apply data knowledge. However, publicly shared data cleaning code documents ways modified original dataset make human-readable. CSV text files considered interoperable.","code":""},{"path":"data-mgmt-plan.html","id":"element-4-data-preservation-access-and-associated-timelines","chapter":"Data Management and Sharing Plan","heading":"Element 4: Data Preservation, Access, and Associated Timelines","text":"","code":""},{"path":"data-mgmt-plan.html","id":"a.-repository-where-scientific-data-and-metadata-will-be-archived","chapter":"Data Management and Sharing Plan","heading":"A. Repository where scientific data and metadata will be archived:","text":"Provide name repository(ies) scientific data metadata arising project archived; see Selecting Data Repository.project complete receive permission , data may archived Databrary (https://databrary.org). Metadata summary data/visualizations archived GitHub, https://gilmore-lab.github.io/visual-acuity/.","code":""},{"path":"data-mgmt-plan.html","id":"b.-how-scientific-data-will-be-findable-and-identifiable","chapter":"Data Management and Sharing Plan","heading":"B. How scientific data will be findable and identifiable:","text":"Describe scientific data findable identifiable, .e., via persistent unique identifier standard indexing tools.project data shared publicly, Databrary create persistent identifier (e.g., DOI).","code":""},{"path":"data-mgmt-plan.html","id":"c.-when-and-how-long-the-scientific-data-will-be-made-available","chapter":"Data Management and Sharing Plan","heading":"C. When and how long the scientific data will be made available:","text":"Describe scientific data made available users (.e., later time associated publication end performance period, whichever comes first) long data available.","code":""},{"path":"data-mgmt-plan.html","id":"element-5-access-distribution-or-reuse-considerations","chapter":"Data Management and Sharing Plan","heading":"Element 5: Access, Distribution, or Reuse Considerations:","text":"","code":""},{"path":"data-mgmt-plan.html","id":"a.-factors-affecting-subsequent-access-distribution-or-reuse-of-scientific-data","chapter":"Data Management and Sharing Plan","heading":"A. Factors affecting subsequent access, distribution, or reuse of scientific data:","text":"NIH expects drafting Plans, researchers maximize appropriate sharing scientific data. Describe justify applicable factors data use limitations affecting subsequent access, distribution, reuse scientific data related informed consent, privacy confidentiality protections, considerations may limit extent data sharing. See Frequently Asked Questions examples justifiable reasons limiting sharing data.","code":""},{"path":"data-mgmt-plan.html","id":"b.-whether-access-to-scientific-data-will-be-controlled","chapter":"Data Management and Sharing Plan","heading":"B. Whether access to scientific data will be controlled:","text":"State whether access scientific data controlled (.e., made available data repository approval).Databrary approve data shared researchers. Authorization upload share data governed formal Databrary Access Agreement binds Databrary New York University researcher’s home institution. DAA gives institutionally authorized researchers right share data materials Databrary consistent policies institution, ethics board approvals, permission research participants. Similarly, researchers can share data Databrary control approve individual access , Databrary require .shared, data project available anyone.","code":""},{"path":"data-mgmt-plan.html","id":"c.-protections-for-privacy-rights-and-confidentiality-of-human-research-participants","chapter":"Data Management and Sharing Plan","heading":"C. Protections for privacy, rights, and confidentiality of human research participants:","text":"generating scientific data derived humans, describe privacy, rights, confidentiality human research participants protected (e.g., de-identification, Certificates Confidentiality, protective measures).","code":""},{"path":"data-mgmt-plan.html","id":"element-6-oversight-of-data-management-and-sharing","chapter":"Data Management and Sharing Plan","heading":"Element 6: Oversight of Data Management and Sharing:","text":"Describe compliance Plan monitored managed, frequency oversight, institution (e.g., titles, roles).PIs project manage provisions.","code":""}]
